Adel K El-Naggar Selected Research

Adel K El-Naggar Research Topics

Disease

159	Neoplasms (Cancer) 11/2023 - 07/2002
45	Squamous Cell Carcinoma of Head and Neck 01/2023 - 11/2002
30	Carcinoma (Carcinomatosis) 11/2023 - 10/2002
27	Carcinogenesis 01/2022 - 02/2002
20	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2002
19	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021 - 02/2002
15	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 10/2004
12	Adenoid Cystic Carcinoma (Cylindroma) 11/2023 - 11/2006
12	Mouth Neoplasms (Oral Cancer) 03/2021 - 01/2008
11	Thyroid Neoplasms (Thyroid Cancer) 06/2020 - 12/2004
10	Anaplastic Thyroid Carcinoma 01/2019 - 12/2004
8	Adenocarcinoma 01/2022 - 12/2002
8	Papillary Thyroid Cancer 10/2017 - 02/2007
6	Mucoepidermoid Carcinoma 10/2017 - 07/2007
5	Disease Progression 01/2021 - 04/2008
5	Sarcoma (Soft Tissue Sarcoma) 04/2017 - 02/2007
4	Salivary Gland Neoplasms (Salivary Gland Cancer) 05/2021 - 07/2005
4	Lymphatic Metastasis 06/2020 - 01/2008
4	Laryngeal Neoplasms (Laryngeal Cancer) 01/2018 - 04/2009
4	Breast Neoplasms (Breast Cancer) 06/2012 - 12/2005
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2011 - 12/2002
4	follicular Thyroid cancer 12/2010 - 06/2006
3	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 09/2005
3	Acinar Cell Carcinoma 08/2020 - 11/2010
3	Margins of Excision 01/2017 - 11/2007
3	Mucositis 01/2016 - 09/2010
3	Tongue Neoplasms (Tongue Neoplasm) 09/2012 - 07/2006
2	Xerostomia 01/2021 - 08/2008
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 04/2017 - 06/2010
2	Extranodal Extension 01/2017 - 01/2016
2	Oropharyngeal Neoplasms 01/2016 - 10/2014

Drug/Important Bio-Agent (IBA)

40	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
24	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2004
22	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2003
17	ErbB Receptors (EGF Receptor)IBA 01/2019 - 03/2004
9	RNA (Ribonucleic Acid)IBA 02/2023 - 01/2004
9	Cetuximab (Erbitux)FDA Link 01/2023 - 07/2007
9	Phosphotransferases (Kinase)IBA 12/2022 - 11/2006
8	Keratins (Keratin)IBA 01/2023 - 07/2003
7	Transcription Factors (Transcription Factor)IBA 02/2023 - 10/2002
7	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016 - 04/2008
6	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 11/2006
6	LigandsIBA 01/2018 - 08/2006
6	RacivirIBA 08/2013 - 06/2006
5	Insulin-Like PeptidesIBA 01/2019 - 12/2002
5	RetinoidsIBA 01/2018 - 07/2005
5	MicroRNAs (MicroRNA)IBA 04/2017 - 10/2010
5	Cadherins (E-Cadherin)IBA 01/2011 - 06/2004
5	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2010 - 04/2006
5	Paclitaxel (Taxol)FDA LinkGeneric 06/2010 - 06/2006
4	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 11/2008
4	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 11/2007
4	tyrosine receptor (receptor, tyrosine)IBA 01/2021 - 11/2007
4	Gefitinib (Iressa)FDA Link 01/2019 - 12/2004
4	ParaffinIBA 01/2018 - 08/2008
4	Glutamic Acid (Glutamate)FDA Link 06/2010 - 06/2005
4	Codon (Codons)IBA 06/2010 - 03/2005
4	Contrast MediaIBA 06/2009 - 03/2004
4	Messenger RNA (mRNA)IBA 05/2009 - 11/2004
4	Epidermal Growth Factor (EGF)IBA 07/2007 - 12/2004
4	AntibodiesIBA 01/2006 - 07/2003
3	Monoclonal AntibodiesIBA 01/2018 - 03/2004
3	ORALIT (ORS)IBA 07/2015 - 11/2008
3	Indicators and Reagents (Reagents)IBA 02/2015 - 11/2002
3	CytosineIBA 10/2010 - 10/2004
3	Mitogen-Activated Protein KinasesIBA 06/2010 - 01/2008
3	Hormones (Hormone)IBA 11/2007 - 06/2005
3	Estrogen Receptor betaIBA 11/2007 - 06/2005
3	Insulin-Like Growth Factor Binding Protein 3IBA 07/2006 - 12/2002
2	Immune Checkpoint ProteinsIBA 03/2021 - 01/2021
2	CarcinogensIBA 03/2021 - 01/2010
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 01/2018
2	TransferasesIBA 01/2019 - 01/2006
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019 - 01/2018
2	Formaldehyde (Formol)FDA Link 01/2018 - 08/2006
2	Retinoic Acid Receptor gammaIBA 01/2018 - 01/2006
2	Immune Checkpoint InhibitorsIBA 01/2018 - 12/2017
2	TensinsIBA 01/2018 - 06/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018 - 06/2010
2	Cyclin D1IBA 10/2016 - 02/2003
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2013 - 07/2007
2	Tumor Biomarkers (Tumor Markers)IBA 04/2013 - 09/2012
2	CytokinesIBA 06/2012 - 06/2010
2	cixutumumabIBA 12/2011 - 07/2007
2	Protein Isoforms (Isoforms)IBA 07/2011 - 07/2005
2	Somatomedin Receptors (Somatomedin Receptor)IBA 02/2011 - 07/2007
2	NF-kappa B (NF-kB)IBA 01/2011 - 08/2006
2	beta CateninIBA 01/2011 - 03/2005
2	Small Interfering RNA (siRNA)IBA 12/2010 - 05/2009
2	GuanineIBA 10/2010 - 06/2010

Therapy/Procedure

36	Therapeutics 01/2023 - 07/2002
34	Radiotherapy 11/2023 - 11/2002
14	Drug Therapy (Chemotherapy) 12/2022 - 07/2002
6	Neck Dissection (Radical Neck Dissection) 12/2021 - 08/2005
5	Chemoprevention 01/2018 - 04/2008
5	Induction Chemotherapy 01/2016 - 12/2003
4	Immunotherapy 12/2022 - 01/2018
4	Adjuvant Radiotherapy 12/2016 - 08/2004
2	Proton Therapy 01/2021 - 01/2021
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2016 - 11/2010